Ocular Therapeutix, Inc.
OCUL
$7.45
-$0.49-6.17%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -193.51M | -174.34M | -138.36M | -115.27M | -80.74M |
| Total Depreciation and Amortization | 3.79M | 3.79M | 3.72M | 3.42M | 2.98M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.27M | 70.48M | 55.97M | 45.62M | 14.93M |
| Change in Net Operating Assets | -10.23M | -17.64M | -10.21M | -17.92M | -7.41M |
| Cash from Operations | -134.68M | -117.70M | -88.88M | -84.15M | -70.23M |
| Capital Expenditure | -1.29M | -1.55M | -1.72M | -2.96M | -6.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.29M | -1.55M | -1.72M | -2.96M | -6.09M |
| Total Debt Issued | -- | 0.00 | 82.47M | 82.47M | 84.47M |
| Total Debt Repaid | -- | 0.00 | -26.13M | -26.13M | -28.13M |
| Issuance of Common Stock | 332.11M | 435.77M | 432.36M | 439.81M | 118.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -5.18M | -5.18M | -5.18M |
| Cash from Financing | 332.11M | 435.77M | 483.52M | 490.97M | 169.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.15M | 316.52M | 392.93M | 403.86M | 93.51M |
